Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Nov;89(11):1014-7.
doi: 10.1136/adc.2003.046219.

Cancers and immune related diseases associated with Down's syndrome: a record linkage study

Affiliations

Cancers and immune related diseases associated with Down's syndrome: a record linkage study

M J Goldacre et al. Arch Dis Child. 2004 Nov.

Abstract

Objective: To determine the risk of cancers and selected immune related diseases in people with Down's syndrome, relative to risk in other people.

Design: Cohort analysis of a linked dataset of abstracts of hospital and death records; results expressed as the ratios of rates of disease in people with and without Down's syndrome.

Setting: The former Oxford health region, England, 1963-1999.

Subjects: Cohort of 1453 people with Down's syndrome and cohort of 460,000 people with other conditions for comparison.

Main outcomes: As expected, the rate ratio for leukaemia was substantially elevated in people with Down's syndrome: it was 19-fold higher (95% confidence intervals 10.4 to 31.5) than the rate in the comparison cohort. For other cancers combined, excluding leukaemia, the rate ratio was not significantly elevated (1.2; 0.6 to 2.2). The risk of testicular cancer was increased (12.0; 2.5 to 35.6), although this was based on only three cases in the cohort of subjects with Down's syndrome. Significantly elevated risks were found for coeliac disease (4.7; 1.3 to 12.2), acquired hypothyroidism (9.4; 3.4, 20.5), other thyroid disorders, and type 1 diabetes mellitus (2.8; 1.0 to 6.1). A decreased risk was found for asthma (0.4; 0.2 to 0.6).

Conclusions: Our data add to the body of information on the risks of co-morbidity in people with Down's syndrome. The finding on asthma needs to be confirmed or refuted by other studies.

PubMed Disclaimer

References

    1. Lancet. 2000 Jan 15;355(9199):165-9 - PubMed
    1. Thorax. 2000 Aug;55 Suppl 1:S2-10 - PubMed
    1. QJM. 2000 Oct;93(10):669-75 - PubMed
    1. Can J Urol. 2001 Feb;8(1):1203-6 - PubMed
    1. Am J Med Genet. 2001 Jan 1;98(1):70-4 - PubMed

Publication types